CliffBio

Acrotech Biopharma

Patent cliffs & loss of exclusivity

Specialty Pharmaceuticals

Company

Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/acrotech-biopharma
LinkedIn URLhttps://www.linkedin.com/company/acrotech-biopharma/
Twitter URLhttps://twitter.com/acrotechbio
Official Websitehttp://acrotechbiopharma.com

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. Zevalinibritumomab tiuxetanBiologicFeb 2014
  2. BELEODAQBELINOSTATSmall mol.Oct 2027
  3. EVOMELAMELPHALAN HYDROCHLORIDESmall mol.Jan 2034
  4. ADQUEYDIFAMILASTSmall mol.Dec 2036
  5. KHAPZORYLEVOLEUCOVORINSmall mol.Mar 2039
  6. KHAPZORYLEVOLEUCOVORINSmall mol.Mar 2039
  7. MARQIBO KITVINCRISTINE SULFATESmall mol.—
  8. FUSILEVLEVOLEUCOVORIN CALCIUMSmall mol.—
  9. FOLOTYNPRALATREXATESmall mol.—
  10. FOLOTYNPRALATREXATESmall mol.—
  11. FUSILEVLEVOLEUCOVORIN CALCIUMSmall mol.—
  12. FUSILEVLEVOLEUCOVORIN CALCIUMSmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Acrotech Biopharma — patent cliffs & loss of exclusivity | CliffBio